--- title: 'Switching Semaglutide to Tirzepatide: Full Dosage Chart Guide' date: '2026-09-13' slug: switching-semaglutide-to-tirzepatide-full-dosage-chart-guide description: Learn how to switch from semaglutide to tirzepatide with a clear dosage chart, step‑by‑step steps, tracking tips, and Pepio tools for a smooth transition. updated: '2026-09-13' image: https://images.unsplash.com/photo-1779976706581-d4557f21489d?crop=entropy&cs=tinysrgb&fit=max&fm=jpg&ixid=M3w1NDkxOTh8MHwxfHNlYXJjaHwxfHwlN0IlMjdrZXl3b3JkJTI3JTNBJTIwJTI3c3dpdGNoaW5nJTIwZnJvbSUyMHNlbWFnbHV0aWRlJTIwdG8lMjB0aXJ6ZXBhdGlkZSUyMGRvc2FnZSUyMGNoYXJ0JTI3JTJDJTIwJTI3dHlwZSUyNyUzQSUyMCUyN3F1ZXN0aW9uJTI3JTJDJTIwJTI3c2VhcmNoX2ludGVudCUyNyUzQSUyMCUyN3VzZXIlMjBsb29rcyUyMGZvciUyMGElMjB2aXN1YWwlMjBjaGFydCUyMHRoYXQlMjBvdXRsaW5lcyUyMGRvc2UlMjBhZGp1c3RtZW50cyUyMHdoZW4lMjBjaGFuZ2luZyUyMGZyb20lMjBzZW1hZ2x1dGlkZSUyMHRvJTIwdGlyemVwYXRpZGUlMjclMkMlMjAlMjdleGFtcGxlX3F1ZXJ5JTI3JTNBJTIwJTI3V2hhdCUyMGlzJTIwdGhlJTIwZG9zYWdlJTIwY2hhcnQlMjBmb3IlMjBzd2l0Y2hpbmclMjBmcm9tJTIwc2VtYWdsdXRpZGUlMjB0byUyMHRpcnplcGF0aWRlJTNGJTI3JTdEfGVufDB8fHx8MTc4OTI2ODgyNHww&ixlib=rb-4.1.0&q=80&w=400 author: Dr. Benjamin Paul site: 'Pepio: GLP-1 Peptide Tracker' --- # Switching Semaglutide to Tirzepatide: Full Dosage Chart Guide ## How to Transition from Semaglutide to Tirzepatide Using a Dosage Chart Switching from semaglutide to tirzepatide can be tricky without a clear plan. If you search for "how to transition from semaglutide to tirzepatide," you want a clear, practical plan that preserves dose history and avoids gaps. A simple dosage chart helps you see when doses changed, where shots happened, and how symptoms tracked over time. There is no one-to-one milligram equivalence between the two drugs, so clinicians must individualize any conversion and plan (see [JoinMIDI’s guide](https://www.joinmidi.com/post/semaglutide-to-tirzepatide-dose-conversion)). Professional guidance also suggests a short wash-out and close monitoring of blood glucose and side-effects during the switch ([Pharmaceutical Journal](https://pharmaceutical-journal.com/article/ld/switching-between-weight-loss-medications)). - Your latest prescription or clinician instructions - Your recent semaglutide dose history or exported notes - A place to record the chart (paper, spreadsheet, or an app like Pepio) Keep the chart updated and share it with your clinician. Learn more about Pepio’s approach to organizing medication switches and dose history. ## Step‑by‑Step Transition Process This section walks through practical semaglutide to tirzepatide transition steps you can use with your clinician and tracking tool. Use these steps to prepare a clear plan, preserve dose history, and collect symptom data during the switch. The sequence below follows the common clinical practice for transitions while emphasizing clinician oversight. 1. Step 1: Confirm your new tirzepatide prescription — Verify the exact starting dose and any titration schedule with your clinician. - **Why it matters**: Guarantees you start with the dose your clinician intended. - **Pitfall**: Assuming the new starting dose equals your last semaglutide dose. 2. Step 2: Export your current semaglutide log from your tracker — Save or copy the last 4–6 weeks of injection dates, doses, and sites. - **Why it matters**: Provides a reliable baseline for dose mapping and comparison. - **Pitfall**: Missing entries create gaps that confuse the conversion timeline. 3. Step 3: Map semaglutide doses to tirzepatide equivalents — Use an accepted dose conversion chart and mark the corresponding tirzepatide dose for each week. - **Why it matters**: Helps align exposure patterns during the transition. - **Pitfall**: Ignoring chart footnotes about weekly versus biweekly dosing or special cases. 4. Step 4: Create a visual dosage chart — Plot weeks on the x-axis and dose (mg) on the y-axis, showing semaglutide weeks in one color and tirzepatide weeks in another. - **Why it matters**: A visual view clarifies when overlap ends and the new regimen begins. - **Pitfall**: Forgetting to label injection sites, which can lead to poor rotation. 5. Step 5: Enter the tirzepatide schedule into your tracker — Use Pepio’s Tirzepatide Titration Schedule tool to generate your week‑by‑week plan and calendar reminders (ICS). In the Pepio iOS app, set push reminders and log each dose as you take it to maintain a continuous history. - **Why it matters**: Keeps the new routine and history in one place to prevent fragmented notes. - **Pitfall**: Overwriting past semaglutide history instead of creating a continuous record. 6. Step 6: Log symptoms and food-noise during the transition — Record nausea, appetite changes, and any new side effects daily. - **Why it matters**: Daily symptom data helps you and your clinician spot patterns needing attention. - **Pitfall**: Skipping daily logs reduces the dataset and hides trends. 7. Step 7: Review the chart with your clinician before the first tirzepatide dose — Bring the printed or digital chart and your symptom summary to the appointment. - **Why it matters**: Ensures medical oversight and confirms the plan matches your health goals. - **Pitfall**: Treating the chart as a substitution for medical review. ### Clinical guardrails and practice findings There is no universal, one-size-fits-all equivalence between semaglutide and tirzepatide. Clinicians individualize conversions based on history, tolerability, and goals. Clinical practice mappings commonly cited suggest semaglutide 0.5 mg maps to tirzepatide 2.5 mg, semaglutide 1 mg maps to tirzepatide 5 mg, and semaglutide 2 mg maps to tirzepatide 5–7.5 mg (reported as clinical practice findings) ([Doctronic – Dose Conversion](https://www.doctronic.ai/blog/semaglutide-to-tirzepatide-dose-conversion)). Many clinicians start tirzepatide at a low dose and titrate every four weeks to support GI tolerance, which aligns with guidance summarized in specialist resources ([JoinMIDI – Dose Conversion](https://www.joinmidi.com/post/semaglutide-to-tirzepatide-dose-conversion); [The Pharmaceutical Journal – Switching between weight‑loss medications](https://pharmaceutical-journal.com/article/ld/switching-between-weight-loss-medications)). Expect closer blood‑glucose monitoring during the first 4–8 weeks after the switch, since tirzepatide can affect A1C more aggressively than semaglutide ([Doctronic – Dose Conversion](https://www.doctronic.ai/blog/semaglutide-to-tirzepatide-dose-conversion)). - Use consistent colors for each medication - Label injection sites next to each dose point - Add a column for symptom severity Include axes labeled “Week” and “Dose (mg),” a small column for injection-site notes, and a symptom-severity column scored simply (none, mild, moderate, severe). Add a short washout or overlap row for clinician notes and any recommended observation windows. Tools like Pepio help keep organized dose history, symptom logs, and exportable CSV/PDF reports; the iOS app also provides weight and symptom trend charts over time for easier review without replacing clinician judgment. ### Wrapping up and next steps A clear, shared chart makes transitions safer and smoother. Pepio helps you keep the dose history, reminders, and symptom notes in one organized place so you can present a concise report to your clinician. Users who track complete logs experience fewer data gaps when discussing titration or side effects with their provider. Learn more about Pepio’s approach to organizing transitions and dose history as part of routine management. ### Disclaimer Pepio is for organization and self‑tracking only. This guide does not provide medical advice, dosing recommendations, or clinical instructions. Always follow the instructions from your clinician, prescriber, pharmacist, or medication label, and contact a healthcare professional for concerning or severe symptoms. ## Troubleshooting Common Issues During the Switch Switching medications can raise small but important issues. This section covers troubleshooting semaglutide to tirzepatide transition problems and quick remedies. Remember, there is no direct mg‑to‑mg equivalence. Clinicians individualize transitions based on response and tolerance ([JoinMIDI](https://www.joinmidi.com/post/semaglutide-to-tirzepatide-dose-conversion); [Doctronic](https://www.doctronic.ai/blog/semaglutide-to-tirzepatide-dose-conversion/)). # - Missed semaglutide dose → add a 'gap' row in the chart and discuss with clinician. - Unexpected nausea spikes → verify tirzepatide dose matches chart; log severity in Pepio. - Injection site confusion → Use Pepio’s Injection Site Rotation Planner (web) or the iOS app’s automatic injection‑site rotation memory; set app reminders to keep to your schedule. Increase symptom and glucose logging for the first 4–8 weeks after the switch. More frequent notes help clinicians see timing and severity. If you have type‑2 diabetes, track glucose trends alongside symptoms. Many clinicians find this data useful when adjusting a new regimen ([Pharmaceutical Journal](https://pharmaceutical-journal.com/article/ld/switching-between-weight-loss-medications)). A practical tip: Timing of the switch should be individualized by your prescriber. Some clinicians allow switching without a wash‑out, while others prefer a short interval—confirm the plan with your clinician and document it in your Pepio log. ([JoinMIDI](https://www.joinmidi.com/post/semaglutide-to-tirzepatide-dose-conversion); [Pharmaceutical Journal](https://pharmaceutical-journal.com/article/ld/switching-between-weight-loss-medications)). Still, confirm timing with your prescriber and document the change in your dose history. If chart alignment looks off, re‑confirm dose mapping with your clinician before making any schedule changes. If unexpected symptoms or glucose changes occur, contact your clinician promptly. Use Pepio to keep a clear, time‑stamped record of doses, symptoms, and site rotations so your next visit is more productive. Learn more about Pepio’s approach to tracking routine changes and keeping dose history organized. ## Quick Reference Checklist & Next Steps Use this quick checklist to consolidate records before switching from semaglutide to tirzepatide. Keep notes clear so your clinician can review dose history and symptoms easily. - Confirm your tirzepatide prescription details (brand, strength, concentration) and record them in Pepio's medication settings. - Export your semaglutide dose history as CSV or PDF from Pepio's iOS app or free web tracker so records are ready for review. - Use Pepio's Semaglutide vs. Tirzepatide reference and dose calculators to fill a conversion chart for your notes (reference only, not dosing advice). - Generate a tirzepatide titration calendar with Pepio’s FDA‑label schedule and add downloadable reminders or iOS push notifications. - Track daily symptoms with Pepio’s GLP‑1 Symptom Log (web or iOS), note timing and severity, and export logs for appointments. - Review the compiled chart and exports with your clinician and bring Pepio's Doctor Visit Prep notes to guide the conversation. Note: Pepio's web tools are free and run locally in your browser for privacy. No standardized semaglutide-to-tirzepatide conversion exists, so clinicians individualize dosing ([JoinMIDI – Semaglutide to Tirzepatide Dose Conversion Guide](https://www.joinmidi.com/post/semaglutide-to-tirzepatide-dose-conversion)). Conversion charts can help as a starting point, but they are not dosing rules ([Doctronic – Semaglutide to Tirzepatide Dose Conversion Guide](https://www.doctronic.ai/blog/semaglutide-to-tirzepatide-dose-conversion/)). Always follow your prescriber’s instructions and monitor glucose and other clinical signs closely. Pepio helps you keep dose history, schedules, and symptom notes together during a medication transition. Pepio's approach to routine organization makes it easier to present clean records at follow-up visits. Learn more about Pepio's approach to keeping medication switches organized. Pepio is for organization and self-tracking only. Pepio does not provide medical advice, diagnosis, treatment, dosing recommendations, or protocol recommendations. Always follow the instructions from your clinician, prescriber, pharmacist, medication label, or care team.